HLB Genex, Inc. (KOSDAQ:187420)

South Korea · Delayed Price · Currency is KRW

2,445.00

+85.00 (3.60%)

At close: Nov 2, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Enzyme/Material Business	43.37B	35.42B	25.50B	27.80B	25.87B
New Drug Development	2.09M	9.35M	1.51B	-	-
Total	43.37B	35.43B	27.01B	27.80B	25.87B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea	25.46B	23.62B	18.36B	17.04B	18.40B
Netherlands	8.54B	4.55B	2.63B	4.61B	1.34B
Taiwan	3.31B	2.29B	-	-	-
China	806.55M	357.31M	-	-	-
USA	2.17B	2.38B	1.54B	1.78B	1.98B
UK	731.26M	738.00M	1.96B	1.44B	1.51B
Other	2.35B	1.49B	1.72B	2.93B	2.65B
Thailand	-	-	809.55M	-	-
Total	43.37B	35.43B	27.01B	27.80B	25.87B